Inhibitors of the cyclo-oxygenase component of prostaglandin-H-2 synthetase, namely indomethacin and ibuprofen, are commonly used in the treatment of hemodynamically significant patent ductus arteriosus. These drugs are associated with serious adverse events, including gastrointestinal perforation, renal failure and bleeding. The role of paracetamol, an inhibitor of the peroxidase component of prostaglandin-H-2 synthetase, has been proposed for the treatment of patent ductus arteriosus. We report a series of 8 neonates (birth weight: 724 +/- 173 g; gestational age: 26 +/- 2 weeks) treated with paracetamol for a hemodynamically significant patent ductus arteriosus, because of contraindications to ibuprofen or indomethacin. Successful closure was achieved in 6 out of 8 babies (75%). Median ductal diameter was significantly reduced after treatment (from 1.2 mm, range 1.0-2.5 mm to 0.6 mm, range 0.0-2.5 mm, p = 0.038). No adverse or side effects were observed during treatment. On the basis of these results, paracetamol could be considered a promising and safe therapy for the treatment of patent ductus arteriosus in neonates.

Efficacy of paracetamol for the treatment of patent ductus arteriosus in preterm neonates / Terrin, Gianluca; Conte, Francesca; Antonella, Scipione; Erica, Bacchio; Conti, MARIA GIULIA; Ferro, Rosalia; Ventriglia, Flavia; DE CURTIS, Mario. - In: THE ITALIAN JOURNAL OF PEDIATRICS. - ISSN 1824-7288. - ELETTRONICO. - 40:1(2014), pp. 21-24. [10.1186/1824-7288-40-21]

Efficacy of paracetamol for the treatment of patent ductus arteriosus in preterm neonates

TERRIN, GIANLUCA;CONTE, FRANCESCA;CONTI, MARIA GIULIA;FERRO, Rosalia;VENTRIGLIA, Flavia;DE CURTIS, MARIO
2014

Abstract

Inhibitors of the cyclo-oxygenase component of prostaglandin-H-2 synthetase, namely indomethacin and ibuprofen, are commonly used in the treatment of hemodynamically significant patent ductus arteriosus. These drugs are associated with serious adverse events, including gastrointestinal perforation, renal failure and bleeding. The role of paracetamol, an inhibitor of the peroxidase component of prostaglandin-H-2 synthetase, has been proposed for the treatment of patent ductus arteriosus. We report a series of 8 neonates (birth weight: 724 +/- 173 g; gestational age: 26 +/- 2 weeks) treated with paracetamol for a hemodynamically significant patent ductus arteriosus, because of contraindications to ibuprofen or indomethacin. Successful closure was achieved in 6 out of 8 babies (75%). Median ductal diameter was significantly reduced after treatment (from 1.2 mm, range 1.0-2.5 mm to 0.6 mm, range 0.0-2.5 mm, p = 0.038). No adverse or side effects were observed during treatment. On the basis of these results, paracetamol could be considered a promising and safe therapy for the treatment of patent ductus arteriosus in neonates.
2014
ibuprofen; indomethacin; paracetamol; cox-inhibitors; patent ductus arteriosus
01 Pubblicazione su rivista::01a Articolo in rivista
Efficacy of paracetamol for the treatment of patent ductus arteriosus in preterm neonates / Terrin, Gianluca; Conte, Francesca; Antonella, Scipione; Erica, Bacchio; Conti, MARIA GIULIA; Ferro, Rosalia; Ventriglia, Flavia; DE CURTIS, Mario. - In: THE ITALIAN JOURNAL OF PEDIATRICS. - ISSN 1824-7288. - ELETTRONICO. - 40:1(2014), pp. 21-24. [10.1186/1824-7288-40-21]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/555292
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 49
  • ???jsp.display-item.citation.isi??? 45
social impact